Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Belite Bio, Inc - American Depositary Shares
(NQ:
BLTE
)
48.68
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Belite Bio, Inc - American Depositary Shares
< Previous
1
2
3
4
5
Next >
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
September 01, 2022
Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) jumped 48.5% to $19.90 after Novo Nordisk announced it will acquire the company for $20 per share in cash.
Via
Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
Vipshop Holdings, Signify Health And Other Big Gainers From Monday
August 23, 2022
U.S. stocks closed sharply lower with the Nasdaq Composite dropping more than 300 points on Monday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Belite Bio Starts Enrollment In Pivotal Lead Asset Study In Inherited Eye Disease
August 22, 2022
Via
Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
Belite Bio Shares Gain On Initiation Of Late-Stage Retinal Disease Study
August 22, 2022
Belite Bio (NASDAQ: BLTE) has initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no...
Via
Benzinga
Wayfair, Bed Bath & Beyond And Other Big Losers From Friday
August 22, 2022
U.S. stocks closed lower with the Nasdaq Composite dropping 260 points on Friday. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
August 22, 2022
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.
Via
Benzinga
'Novel Approach For Retinal Disease Needs' Stock Belite Bio Has 70% Potential Upside According To This Analyst
August 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
Upgrades
Via
Benzinga
WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
July 25, 2022
Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 22, 2022
Gainers
Via
Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
July 22, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
July 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...
Via
Benzinga
Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study
July 19, 2022
Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 06, 2022
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022
July 01, 2022
Upgrades
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; US Retail Sales Drop In May
June 15, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 14, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 14, 2022
Via
Benzinga
82 Biggest Movers From Yesterday
June 15, 2022
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
Via
Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
June 14, 2022
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is reportedly expected to file for bankruptcy.
Via
Benzinga
93 Biggest Movers From Yesterday
June 14, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...
Via
Benzinga
70 Stocks Moving In Monday's Mid-Day Session
June 13, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...
Via
Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
May 22, 2022
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.